Pharmena S.A. (PHR) — Cash Flow Reinvestment Rate

Latest as of June 2023: 0.08x

Pharmena S.A. (PHR) has a Cash Flow Reinvestment Rate of 0.08x as of June 2023, reinvesting zł3.53 Million (capex zł131.00K plus investments zł-3.40 Million) from operating cash flow of zł44.83 Million. Check earnings quality score of Pharmena S.A. to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.08x
(Capex + Investments) / Operating CF

Total Reinvested

zł3.53 Million
Capex + Investments

Operating Cash Flow

zł44.83 Million
PLN

Capital Expenditures

zł131.00K
PLN

Pharmena S.A. Cash Flow Reinvestment Rate (2011–2023)

Historical reinvestment intensity for Pharmena S.A. across 5 annual periods. Explore cash flow to debt ratio of Pharmena S.A. to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Pharmena S.A. (2011–2023)

Year-by-year capital reinvestment analysis for Pharmena S.A.. For live market cap and broader valuation context, see Pharmena S.A. stock valuation.

Year Reinvestment Rate Total Reinvested (PLN) Operating CF Capex YoY Change
2023 0.10x zł3.45 Million zł33.03 Million zł314.00K ▼ -17.5%
2022 0.13x zł230.00K zł1.82 Million zł226.00K ▼ -48.8%
2018 0.25x zł892.00K zł3.61 Million zł446.00K ▼ -22.4%
2017 0.32x zł197.00K zł619.00K zł197.00K ▲ +208.1%
2011 0.10x zł68.89K zł666.91K zł68.89K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow